<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Atacand Plus</title><link>http://www.unboundmedicine.com/medline/ebm/research/Atacand_Plus</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Olmesartan medoxomil : a review of its use in the management of hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18547134/full_citation/Olmesartan_medoxomil_:_a_review_of_its_use_in_the_management_of_hypertension_</link><description>Scott LJ, McCormack PL <br/><span class="title">Olmesartan medoxomil : a review of its use in the management of hypertension. [Journal Article]</span><br/><span class="source" title="Drugs">Drugs 2008; 68(9):1239-72.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18547134/abstract/Olmesartan_medoxomil_:_a_review_of_its_use_in_the_management_of_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18547134/full_citation/Olmesartan_medoxomil_:_a_review_of_its_use_in_the_management_of_hypertension_">Full Citation</a></description></item><item><title>Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17907102/full_citation/Efficacy_and_tolerability_of_candesartan_cilexetil/hydrochlorothiazide_and_amlodipine_in_patients_with_poorly_controlled_mild_to_moderate_essential_hypertension_</link><description>Fogari R, Mugellini A, Derosa G <br/><span class="title">Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension. [Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Journal of the renin-angiotensin-aldosterone system : JRAAS">J Renin Angiotensin Aldosterone Syst 2007 Sep; 8(3):139-44.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17907102/abstract/Efficacy_and_tolerability_of_candesartan_cilexetil/hydrochlorothiazide_and_amlodipine_in_patients_with_poorly_controlled_mild_to_moderate_essential_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17907102/full_citation/Efficacy_and_tolerability_of_candesartan_cilexetil/hydrochlorothiazide_and_amlodipine_in_patients_with_poorly_controlled_mild_to_moderate_essential_hypertension_">Full Citation</a> | <a href="http://jra.sagepub.com/cgi/pmidlookup%3fview=long%26amp;pmid=17907102">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/17907102/Efficacy_and_tolerability_of_candesartan_cilexetil/hydrochlorothiazide_and_amlodipine_in_patients_with_poorly_controlled_mild_to_moderate_essential_hypertension_">Find Related Articles</a> </description></item><item><title>Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.</title><link>http://www.unboundmedicine.com/medline/ebm/record/17176359/full_citation/Carvedilol_accelerate_elevation_of_serum_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_or_candesartan_cilexetil_</link><description>Saito M, Nakayama D, Takada M, et al. <br/><span class="title">Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. [Journal Article]</span><br/><span class="source" title="Journal of clinical pharmacy and therapeutics">J Clin Pharm Ther 2006 Dec; 31(6):535-40.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/17176359/abstract/Carvedilol_accelerate_elevation_of_serum_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_or_candesartan_cilexetil_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/17176359/full_citation/Carvedilol_accelerate_elevation_of_serum_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_or_candesartan_cilexetil_">Full Citation</a></description></item><item><title>Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16336294/full_citation/Serum_concentration_of_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_losartan_potassium_or_candesartan_cilexetil_</link><description>Saito M, Takada M, Hirooka K, et al. <br/><span class="title">Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil. [Clinical Trial, Journal Article]</span><br/><span class="source" title="Journal of clinical pharmacy and therapeutics.">J Clin Pharm Ther 2005 Dec; 30(6):603-10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16336294/abstract/Serum_concentration_of_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_losartan_potassium_or_candesartan_cilexetil_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16336294/full_citation/Serum_concentration_of_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_losartan_potassium_or_candesartan_cilexetil_">Full Citation</a> | <a href="http://www.blackwell-synergy.com/openurl%3fgenre=article%26amp;sid=nlm:pubmed%26amp;issn=0269-4727%26amp;date=2005%26amp;volume=30%26amp;issue=6%26amp;spage=603">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16336294/Serum_concentration_of_potassium_in_chronic_heart_failure_patients_administered_spironolactone_plus_furosemide_and_either_enalapril_maleate_losartan_potassium_or_candesartan_cilexetil_">Find Related Articles</a> </description></item><item><title>Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers.</title><link>http://www.unboundmedicine.com/medline/ebm/record/16236687/full_citation/Efficacy_and_safety_of_combination_therapy_using_high__or_low_dose_hydrochlorothiazide_with_valsartan_or_other_Angiotensin_receptor_blockers_</link><description>Fuenfstueck R, Hempel RD, Ansari A, et al. <br/><span class="title">Efficacy and safety of combination therapy using high- or low-dose hydrochlorothiazide with valsartan or other Angiotensin-receptor blockers. [Clinical Trial, Journal Article, Multicenter Study]</span><br/><span class="source" title="Advances in therapy.">Adv Ther 2005 May-Jun; 22(3):263-77.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/16236687/abstract/Efficacy_and_safety_of_combination_therapy_using_high__or_low_dose_hydrochlorothiazide_with_valsartan_or_other_Angiotensin_receptor_blockers_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/16236687/full_citation/Efficacy_and_safety_of_combination_therapy_using_high__or_low_dose_hydrochlorothiazide_with_valsartan_or_other_Angiotensin_receptor_blockers_">Full Citation</a> | <a href="http://openurl.ingenta.com/content/nlm%3fgenre=article%26amp;issn=1175-3277%26amp;volume=5%26amp;issue=1%26amp;spage=41%26amp;aulast=Smith">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/16236687/Efficacy_and_safety_of_combination_therapy_using_high__or_low_dose_hydrochlorothiazide_with_valsartan_or_other_Angiotensin_receptor_blockers_">Find Related Articles</a> </description></item><item><title>Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15662234/full_citation/Controlled_release_nifedipine_and_candesartan_low_dose_combination_therapy_in_patients_with_essential_hypertension:_the_NICE_Combi__Nifedipine_and_Candesartan_Combination__Study_</link><description>Hasebe N, Kikuchi K <br/><span class="title">Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study. [Clinical Trial, Journal Article, Randomized Controlled Trial]</span><br/><span class="source" title="Journal of hypertension. ">J Hypertens 2005 Feb; 23(2):445-53.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15662234/abstract/Controlled_release_nifedipine_and_candesartan_low_dose_combination_therapy_in_patients_with_essential_hypertension:_the_NICE_Combi__Nifedipine_and_Candesartan_Combination__Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15662234/full_citation/Controlled_release_nifedipine_and_candesartan_low_dose_combination_therapy_in_patients_with_essential_hypertension:_the_NICE_Combi__Nifedipine_and_Candesartan_Combination__Study_">Full Citation</a> | <a href="http://dx.doi.org/10.1038/sj.jhh.1001769">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15662234/Controlled_release_nifedipine_and_candesartan_low_dose_combination_therapy_in_patients_with_essential_hypertension:_the_NICE_Combi__Nifedipine_and_Candesartan_Combination__Study_">Find Related Articles</a> </description></item><item><title>Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15631278/full_citation/Candesartan_plus_hydrochlorothiazide_fixed_combination_vs_previous_monotherapy_plus_diuretic_in_poorly_controlled_essential_hypertensive_patients_</link><description>Mancia G, Omboni S <br/><span class="title">Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="Blood pressure.  Supplement. ">Blood Press Suppl 2004 Dec.:11-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15631278/abstract/Candesartan_plus_hydrochlorothiazide_fixed_combination_vs_previous_monotherapy_plus_diuretic_in_poorly_controlled_essential_hypertensive_patients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15631278/full_citation/Candesartan_plus_hydrochlorothiazide_fixed_combination_vs_previous_monotherapy_plus_diuretic_in_poorly_controlled_essential_hypertensive_patients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15631278/Candesartan_plus_hydrochlorothiazide_fixed_combination_vs_previous_monotherapy_plus_diuretic_in_poorly_controlled_essential_hypertensive_patients_">Find Related Articles</a> </description></item><item><title>Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15365275/full_citation/Antihypertensive_efficacy_of_candesartan_lisinopril_in_combination_vs__up_titration_of_lisinopril:_the_AMAZE_trials_</link><description>Izzo JL, Weinberg MS, Hainer JW, et al. <br/><span class="title">Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]</span><br/><span class="source" title="Journal of clinical hypertension (Greenwich, Conn.)  ">J Clin Hypertens (Greenwich) 2004 Sep; 6(9):485-93.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15365275/abstract/Antihypertensive_efficacy_of_candesartan_lisinopril_in_combination_vs__up_titration_of_lisinopril:_the_AMAZE_trials_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15365275/full_citation/Antihypertensive_efficacy_of_candesartan_lisinopril_in_combination_vs__up_titration_of_lisinopril:_the_AMAZE_trials_">Full Citation</a> | <a href="http://www.lejacq.com/articleDetail.cfm%3fpid=JClinHypertens_6;9:485">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15365275/Antihypertensive_efficacy_of_candesartan_lisinopril_in_combination_vs__up_titration_of_lisinopril:_the_AMAZE_trials_">Find Related Articles</a> </description></item><item><title>Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15295613/full_citation/Beneficial_action_of_candesartan_cilexetil_plus_amlodipine_or_ACE_inhibitors_in_chronic_nondiabetic_renal_disease_</link><description>Homma K, Hayashi K, Kanda T, et al. <br/><span class="title">Beneficial action of candesartan cilexetil plus amlodipine or ACE inhibitors in chronic nondiabetic renal disease. [Clinical Trial, Controlled Clinical Trial, Journal Article]</span><br/><span class="source" title="Journal of human hypertension. ">J Hum Hypertens 2004 Dec; 18(12):879-84.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15295613/abstract/Beneficial_action_of_candesartan_cilexetil_plus_amlodipine_or_ACE_inhibitors_in_chronic_nondiabetic_renal_disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15295613/full_citation/Beneficial_action_of_candesartan_cilexetil_plus_amlodipine_or_ACE_inhibitors_in_chronic_nondiabetic_renal_disease_">Full Citation</a> | <a href="http://dx.doi.org/10.1007/s00467-004-1554-5">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15295613/Beneficial_action_of_candesartan_cilexetil_plus_amlodipine_or_ACE_inhibitors_in_chronic_nondiabetic_renal_disease_">Find Related Articles</a> </description></item><item><title>Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension.</title><link>http://www.unboundmedicine.com/medline/ebm/record/15140325/full_citation/Fixed_combination_of_candesartan_with_hydrochlorothiazide_in_patients_with_severe_primary_hypertension_</link><description>Bönner G, Fuchs W <br/><span class="title">Fixed combination of candesartan with hydrochlorothiazide in patients with severe primary hypertension. [Clinical Trial, Journal Article]</span><br/><span class="source" title="Current medical research and opinion. ">Curr Med Res Opin 2004 May; 20(5):597-602.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/15140325/abstract/Fixed_combination_of_candesartan_with_hydrochlorothiazide_in_patients_with_severe_primary_hypertension_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/15140325/full_citation/Fixed_combination_of_candesartan_with_hydrochlorothiazide_in_patients_with_severe_primary_hypertension_">Full Citation</a> | <a href="http://openurl.ingenta.com/content/nlm%3fgenre=article%26amp;issn=0300-7995%26amp;volume=20%26amp;issue=5%26amp;spage=597%26amp;aulast=Bonner">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/15140325/Fixed_combination_of_candesartan_with_hydrochlorothiazide_in_patients_with_severe_primary_hypertension_">Find Related Articles</a> </description></item></channel></rss>